Podiatrists in Abington, PA Accepting Medicare

4 Podiatrists found. Showing 1 - 4

Save Your Soles Podiatry Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 1375 Old York Rd, Abington, PA 19001 Phone: 551-655-7440

Dr. Ronald M. Renzi, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2002 Woodland Rd, Abington, PA 19001 Phone: 215-884-0140    Fax: 215-624-4763

Maikel Griages, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1375 Old York Rd, Abington, PA 19001 Phone: 551-655-7440

Save Your Soles Podiatry Llp Podiatrist Medicare: Medicare Enrolled Practice Location: 2002 Woodland Rd, Abington, PA 19001 Phone: 215-884-0140    Fax: 215-624-4763

News Archive

Many health law exchange plans have 'narrow networks'

Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.

New artificial intelligence system could lead to improved ways to control high ozone problems

Ozone levels in the earth's troposphere (the lowest level of our atmosphere) can now be forecasted with accuracy up to two weeks in advance, a remarkable improvement over current systems that can accurately predict ozone levels only three days ahead.

Bayer Schering Pharma to develop new BiTE antibody for treatment of solid tumors

Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on January 12, 2009 to develop a new BiTE antibody for the treatment of solid tumors.

Reform effort could expand drug coverage, affordability

One impact of health insurance exchanges, proposed by Democrats as part of the health care overhaul, could be better prescription drug coverage for some consumers, the Los Angeles Times explains. The exchanges would require drug coverage as part of a minimum benefits package. The flip side is that some people may be forced to buy drug coverage they don't want.

Read more Medical News

› Verified 3 days ago